Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry

CNS Drugs

Volumn 21, Issue 12, 2007, Pages 1035-1038

  Cohen, Dan ^a,b   Huinink, Saskia ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b De Dijk GGZ NHN ^*  (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adolescents; Children; Diabetes mellitus; Dopamine receptor antagonists, adverse reactions; Olanzapine, adverse reactions; Quetiapine, adverse reactions; Risperidone, adverse reactions

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; GLUCOSE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADOLESCENT; ADULT; CHILD PSYCHIATRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPEROSMOLARITY; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; WEIGHT GAIN;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ANTIPSYCHOTIC AGENTS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MEDICAL RECORDS; SCHIZOPHRENIA;

EID: 36249005413     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721120-00006     Document Type: Letter

References (31)

1. Masi G, Mucci M, Pari C. Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs 2006; 20 (10): 841-66
2. Sporn AL, Bobb AJ, Gogtay N, et al. Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study. J Am Acad Child Adolesc Psychiatry 2005; 44 (9): 925-33
3. Quintana H, Wilson II MS, Purnell W, et al. An open-label study of olanzapine in children and adolescents with schizophrenia. J Psychiatr Pract 2007; 13 (2): 86-96
4. Shaw P, Sporn A, Gogtay N, et al. Childhood-onset schizophrenia. Arch Gen Psychiatry 2006; 63: 721-30
5. Harrison-Woolrych M, Garcia-Quiroga J, Ashton J, et al. Safety and usage of atypical antipsychotic medicines in children. Drug Safety 2007; 30 (7): 569-79
6. Fleischhaker C, Heiser P, Hennghausen K, et al. Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents. J Neural Transm 2007; 11: 273-80
7. Jensen PS, Buitelaar J, Pandina GJ, et al. Management of psychoiatric disorders in children and adolescents with atypical antipsychotics. Eur Child Adolesc Psychiatry 2007; 16 (2): 104-20
8. Patel NC, Crismon ML, Hoagwood K, et al. Trends in use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry 2005; 44 (6): 548-56
9. Olfson M, Blanco C, Liu L, et al. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006; 63: 679-85
10. Bloch Y, Vardi O, Mendlovic S, et al. Hyperglycemia from olanzapine treatment in adolescents. J Child Adolesc Psychopharmacol 2003; 13 (1): 97-102
11. Courvoisie HE, Cooke DW, Riddle MA. Olanzapine-induced diabetes in a seven-year-old boy. J Child Adolesc Psychopharmacol 2004; 14 (4): 612-6
12. Domon SE, Webber JC. Hyperglycemia and hypertriglyceridemia secondary to olanzapine [letter]. J Child Adolesc Psychopharmacol 2001; 11 (3): 285-8
13. Hayek D, Hüttl V, Reiss J, et al. Hyperglycemia and ketoacidosis with olanzapine [in German]. Nervenarzt 1999; 70: 836-7
14. Domon SE, Cargile CS. Quetiapine-associated hyperglycemia and hypertriglyceridemia. J Am Acad Child Adolesc Psychiatry 2002; 41 (5): 495-6
15. Saito E, Kafantaris V. Can diabetes mellitus be induced by medication? J Child Adolesc Psychopharmacol 2002; 12 (3): 231-6
16. Lauwers K, De Hert M. Glucose abnormalities in a non-psychotic patient treated with risperidone [letter]. J Am Acad Child Adolesc Psychiatry 2005; 44 (7): 629-30
17. Selva KA, Scott SM. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatrics 2001; 138 (6): 936-7
18. Paizis M, Cavaleri S, Schwarz ME, et al. Acute-onset diabetic keotacidosis during olanzapine treatment in a patient without pretreatment obesity or treatment-associated weight gain. Prim Psychiatry 1999; 6 (12): 37-8
19. Koller E, Malozowski S, Doraiswamy PM. Atypical antipsychotic drugs and hyperglycemia in adolescents [letter]. JAMA 2001; 286: 2547-8
20. Koller EA, Cross JT, Schneider B. Risperidone-associated diabetes mellitus in children [letter]. Pediatrics 2004; 113: 421-2
21. Hagura R, Matsuda A, Kuzuya T, et al. Family history of diabetic patients in Japan. Diabetes Res Clin Practice 1994; 24 Suppl: 69-73S
22. Blokstra A, Smit HA, Verschuren WMM. Changes in lifestyle factors and risk factors for chronic diseases with ageing: The Doetinchem Study 1987-2002. Bilthoven: National Institute for Public Health and the Environment, 2006. Report no. 260401003
23. Cohen D. Atypical antipsychotics and new onset diabetes mellitus: an overview of the literature. Pharmacopsychiatry 2004; 37: 1-11
24. Basu A, Meltzer HY. Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic era. Schizophrenia Res 2006; 86: 99-109
25. Ramaswamy K, Kozma CM, Nasrallah H. Risk of diabetic ketoacidosis after exposure to risperdone or olanzapine. Drugs Safety 2007; 30 (7): 589-99
26. 'Schizophrenia and Diabetes 2003'. Expert consensus meeting, Dublin, 3-4 October 2003: consensus summary. Br J Psychiatry 2004; 184 (47 Suppl.): 112-4S
27. Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161: 1334-9
28. Melkersson KI, Dahl M-L, Hulting AL. Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism. Psychopharmacol 2004; 175: 1-6
29. Gough S, Peveler R. Diabetes and its prevention: pragmatic solutions for people with schizophrenia. Br J Psychiatry 2004; 184 (47 Suppl.): 106-1S
30. Cohn TA, Sernyak MJ. Metabolic monitoring for patients treated with antipsychotic medications. Can J Psychiatry 2006; 51: 492-501
31. Cohen D. Diabetes mellitus in schizophrenia or schizoaffective disorder: an iatrogenic or endogenic problem? [dissertation]. Haarlem: University of Utrecht, 2006: 91-103